Friday, August 22, 2014 10:21:36 PM
Ebola Spreads in Nigeria; Liberia Has 1,000 Deaths
ABUJA, Nigeria — Aug 22, 2014, 3:44 PM ET
By BASHIR ADIGUN and JONATHAN PAYE-LAYLEH Associated Press
http://abcnews.go.com/Health/wireStory/nigeria-confirms-ebola-cases-25081117
Two alarming new cases of Ebola have emerged in Nigeria, widening the circle of people sickened beyond the immediate group of caregivers who treated a dying airline passenger in one of Africa's largest cities.
The outbreak also continues to spread elsewhere in West Africa, with 142 more cases recorded, bringing the new total to 2,615 with 1,427 deaths, the World Health Organization said Friday.
Most of the new cases are in Liberia, where the government was delivering donated rice to a slum where 50,000 people have been sealed off from the rest of the capital in an attempt to contain the outbreak.
New treatment centers in Liberia are being overwhelmed by patients that were not previously identified. One center with 20 beds opened its doors to 70 possibly infected people, likely coming from "shadow-zones" where people fearing authorities won't let doctors enter, the U.N health agency said.
"This phenomenon strongly suggests the existence of an invisible caseload of patients who are not being detected by the surveillance system," the agency said. This has "never before been seen in an Ebola outbreak."
The two new cases in Nigeria were infected by their spouses, both medical workers who had direct contact with Liberian-American Patrick Sawyer, who flew into Nigeria from Liberia and Togo and infected 11 others before he died in July. The male and female caregivers also then died of Ebola, Health Minister Onyebuchi Chukwu said Friday.
Nigerian officials initially claimed the risk of exposure to others was minimal because Sawyer was whisked into isolation after arriving at the airport. Lagos state health commissioner Jide Idris later acknowledged that Sawyer was not immediately quarantined.
The two new cases were quarantined two days ago while being tested, Chukwu said. They had previously been under surveillance, meaning they were contacted daily to see if they developed any symptoms, but their movements were not restricted. Once they showed signs of the disease, they were brought in.
Authorities are now trying to identify and monitor everyone they have been in contact with.
In all, 213 people are now under surveillance in Nigeria, including six people, all "secondary contacts" like the caregivers' spouses, being monitored in the state of Enugu, more than 310 miles (500 kilometers) east of Lagos.
A mobile laboratory capable of diagnosing the disease has been moved there, Chukwu said.
Nigeria's total of confirmed infections is now 16. Five of them have died and five have recovered; the rest are being treated in isolation in Lagos, the commercial capital where Sawyer's flight landed.
The damage has been far greater in Guinea, Sierra Leone and Liberia, each dealing with hundreds of cases. Liberia has been hit hardest, recording 1,082 cases and 624 deaths.
(the story continues after that point summarizing most of what is already known).
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM